Supply Chain Management in the Drug Industry: Delivering Patient Value for Pharmaceuticals and Biologics (Google eBook)

Front Cover
John Wiley & Sons, Apr 6, 2011 - Medical - 448 pages
1 Review
This book bridges the gap between practitioners of supply-chain management and pharmaceutical industry experts. It aims to help both these groups understand the different worlds they live in and how to jointly contribute to meaningful improvements in supply-chains within the globally important pharmaceutical sector. Scientific and technical staff must work closely with supply-chain practitioners and other relevant parties to help secure responsive, cost effective and risk mitigated supply chains to compete on a world stage. This should not wait until a drug has been registered, but should start as early as possible in the development process and before registration or clinical trials. The author suggests that CMC (chemistry manufacturing controls) drug development must reset the line of sight from supply of drug to the clinic and gaining a registration, to the building of a patient value stream. Capable processes and suppliers, streamlined logistics, flexible plant and equipment, shorter cycle times, effective flow of information and reduced waste. All these factors can and should be addressed at the CMC development stage.
  

What people are saying - Write a review

User Review - Flag as inappropriate

This book guides better about historical context of supply chain management. it depicts in good manner about developments in supply chain literature and current trends.
Thanks to Hedley Rees

Contents

I
II
III
IV
VI
VII
VIII
IX
XI
XII
XIV
XV
XVI
XVII
XVIII
XIX

X

Common terms and phrases

About the author (2011)

Hedley Rees runs the independent consulting company Biotech PharmaFlow, which specializes in pharmaceutical supply chain management. He has been actively building, managing, and continuously improving supply chains in biotech for the last fifteen years.

Bibliographic information